
    
      This is a prospective, single arm, non-randomized clinical study with pre-post assessment to
      include post-stroke and Traumatic Brain Injury (TBI) outpatients with spastic ankle / foot
      muscles amenable to botulinum toxin injection. Subjects must be able to walk without braces.

      AbobotulinumtoxinA injection in a dose range of 500 to 1500 units one time to be distributed
      on the basis of clinical indication to ankle plantar flexors (gastrocnemius and soleus), knee
      extensors, knee flexors, tibialis posterior and long toe flexors.
    
  